Company / Return on Equity (ROE)
Tanke Biosciences Corp Return on Equity (ROE) History
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-1.3%
FY2012
5-year range
-19.8% / -1.3%
FY2011-FY2012
Trend
+93.3%
vs FY2011
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tanke Biosciences Corp reports negative total equity of -1.3% in FY2012. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-1.3% in FY2012.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2012, return on equity (roe) increased 93.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2012 | -1.3% | +93.3% |
| FY2011 | -19.8% | - |
As of FY2012 · SEC 10-K · Updated Jun 29, 2026